Development of celiac-safe foods: prevention of transglutaminase 2 (TG2) deamidation of gluten in healthy non-celiac volunteers
In celiac disease, intestinal transglutaminase (TG2) produces immunogenic peptides by deamidation of gluten proteins. These products drive the celiac immune response. We have previously identified an interaction between gliadin and a food additive, E304i, which prevents gliadin processing (both deam...
Main Authors: | Niklas Engström, Lena Böhn, Axel Josefsson, Stine Störsrud, Nathalie Scheers |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2024.1308463/full |
Similar Items
-
Significance of a method for determination of deamidated gliadin peptide in the diagnosis of celiac disease
by: E A Sabel'nikova, et al.
Published: (2014-02-01) -
Performance of deamidated gliadin peptide antibodies as first screening for celiac disease in the general pediatric population
by: Abdulrahman Al-Hussaini, et al.
Published: (2023-11-01) -
Microbial Transglutaminase Is Immunogenic and Potentially Pathogenic in Pediatric Celiac Disease
by: Matthias Torsten, et al.
Published: (2018-12-01) -
Anti-tissue transglutaminase antibodies and EEG pattern in celiac patients on prolonged gluten-free diet
by: A. Berio, et al.
Published: (2013-01-01) -
The Effect of Xanthan, Guar and Transglutaminase on the Physicochemical and Textural Properties of Gluten-free Doughnut
by: Arezo Fazeli, et al.
Published: (2019-04-01)